StockNews.com assumed coverage on shares of Bellicum Pharmaceuticals ( NASDAQ:BLCM – Free Report ) in a research note released on Wednesday. The firm issued a sell rating on the biopharmaceutical company's stock. Bellicum Pharmaceuticals Stock Performance BLCM opened at $0.39 on Wednesday. The stock's fifty day simple moving average is $0.48 and its 200 day simple moving average is $0.67. Bellicum Pharmaceuticals has a 1-year low of $0.15 and a 1-year high of $1.55. Bellicum Pharmaceuticals ( NASDAQ:BLCM – Get Free Report ) last posted its quarterly earnings data on Thursday, May 11th.

https://www.dailypolitical.com/2023/07/22/bellicum-pharmaceuticals-nasdaqblcm-earns-sell-rating-from-analysts-at-stocknews-com.html

#dailypolitical